These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cancers in cyclosporine-treated vs azathioprine-treated patients. Penn I Transplant Proc; 1996 Apr; 28(2):876-8. PubMed ID: 8623443 [No Abstract] [Full Text] [Related]
7. Incidence and outcomes of infections in cardiac allograft recipients: A Brazilian perspective. Godoy HL; Guerra CM; Viegas RF; Diniz RV; Almeida DR Am J Infect Control; 2010 Mar; 38(2):162-3. PubMed ID: 20176285 [No Abstract] [Full Text] [Related]
8. Phase III study of FK 506 in kidney transplantation. Japanese FK 506 Study Group. Ochiai T; Fukao K; Takahashi K; Endo T; Oshima S; Uchida K; Yokoyama I; Ishibashi M; Takahara S; Iwasaki Y Transplant Proc; 1995 Feb; 27(1):829-33. PubMed ID: 7533435 [No Abstract] [Full Text] [Related]
9. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 4-1985. A 36-year-old man with a cardiac mass three years after renal transplantation. N Engl J Med; 1985 Jan; 312(4):226-37. PubMed ID: 3880868 [No Abstract] [Full Text] [Related]
10. [Malignant tumors following kidney transplantation. Experiences at the tranplantation center in Zurich]. Wegmann W; Largiadèr F; Binswanger U Schweiz Med Wochenschr; 1974 Jun; 104(23):809-14. PubMed ID: 4601389 [No Abstract] [Full Text] [Related]
11. Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression. Gruber SA; Skjei KL; Sothern RB; Robison L; Tzardis P; Moss A; Gillingham K; Canafax DM; Matas AJ; Dunn DL Transplant Proc; 1991 Feb; 23(1 Pt 2):1104-5. PubMed ID: 1989160 [No Abstract] [Full Text] [Related]
12. Cancer development in pediatric primary renal allograft recipients. Gruber SA; Gillingham K; Sothern RB; Stephanian E; Chavers B; Matas AJ; Dunn DL Transplant Proc; 1994 Feb; 26(1):3-4. PubMed ID: 8108991 [No Abstract] [Full Text] [Related]
13. Prolonged graft cold ischemia: a risk factor for early bacterial and fungal infection in liver transplant recipients. Nuño J; Cuervas-Mons V; Vicente E; Turrión V; Pereira F; Mora NP; Barrios C; Millán I; Ardaiz J Transplant Proc; 1995 Aug; 27(4):2323-5. PubMed ID: 7652828 [No Abstract] [Full Text] [Related]
17. Incidence and type of malignancies occurring after renal transplantation in conventionally and in cyclosporine-treated recipients: single-center analysis of a 20-year period in 1600 patients. Hiesse C; Larue JR; Kriaa F; Blanchet P; Bellamy J; Benoit G; Charpentier B Transplant Proc; 1995 Aug; 27(4):2450-1. PubMed ID: 7652877 [No Abstract] [Full Text] [Related]
18. Malignancy in renal recipients. Samhan M; Al-Mousawi M; Donia F; Fathi T; Nasim J; Nampoory MR Transplant Proc; 2005 Sep; 37(7):3068-70. PubMed ID: 16213307 [TBL] [Abstract][Full Text] [Related]
19. Incidence and type of cancer following the use of OKT3: a single center experience with 557 organ transplants. Batiuk TD; Barry JM; Bennett WM; Meyer MM; Tolzman D; Norman DJ Transplant Proc; 1993 Feb; 25(1 Pt 2):1391. PubMed ID: 8382860 [No Abstract] [Full Text] [Related]
20. Risk factor analysis in renal transplantation: guidelines for the management of the transplant recipient. Finkelstein FO; Black HR Am J Med Sci; 1974 Mar; 267(3):159-69. PubMed ID: 4596734 [No Abstract] [Full Text] [Related] [Next] [New Search]